ArticleBMC public health2025
Barriers and facilitators to accessing healthcare for early diagnosis of prostate cancer for black men-a qualitative exploration in North-East England and Scotland.
Article in BMC public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Feasibility and Acceptability of a Group-Based Telehealth Stress Management and Resilience Training Intervention for Men with Prostate Cancer on Active Surveillance.Journal of clinical medicine · 2026Article
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
introductionProstate cancer is the most commonly diagnosed cancer in men in the United Kingdom. There are substantial inequalities in prostate cancer, with Black African and Caribbean men at least twice as likely as White men to develop prostate cancer, and twice as likely to die from it. Black men need to be aware of their elevated risk, which can encourage help-seeking behaviour leading to early diagnosis. This study aimed to investigate barriers and facilitators to accessing healthcare for early diagnosis of prostate cancer for Black men.
methodsBarriers and facilitators were explored through online focus groups with Black men (n = 13) from Scotland and North-East England, who formed the Public Involvement and Community Engagement group for a larger study. Purposive and snowball sampling was used. Focus groups were audio-recorded and transcribed verbatim. Data analysis was iterative. Framework analysis was used and data were mapped onto the Integrated Screening Action Model (I-SAM).
resultsParticipants believed Black men lack prostate cancer knowledge. Additionally, prostate cancer communication needs to use language that Black men could identify with. Participants shared a lack of trust in healthcare providers and perspectives emerged resulting from negative healthcare experiences, including experiences of racism, as barriers to accessing healthcare for early prostate cancer diagnosis. Difficulties with accessing care, including navigating the healthcare system and making appointments, as well as cultural, social and religious factors, were reported as barriers to prostate cancer health checks. Discussing intimate and sensitive issues such as prostate cancer was perceived as difficult for Black men. The involvement of community and religious leaders, along with the collectivist characteristic of the community and the belief in staying healthy for the benefit of the family, were perceived as facilitators.
conclusionBarriers to accessing healthcare for early prostate cancer diagnosis are complex and multifaceted, requiring complex solutions. Asset-based, participatory, and culturally tailored interventions have the potential to be effective in addressing barriers, and thus ultimately reduce morbidity and mortality through earlier diagnosis of prostate cancer in Black communities.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.